Alexandra Garrett, Vera M Kalscheuer, Rebeca Ridings Figueroa, Elizabeth E Palmer, Angela T Morgan
{"title":"CLCN4-Related Neurodevelopmental Condition: Characterization of Speech and Language Abilities.","authors":"Alexandra Garrett, Vera M Kalscheuer, Rebeca Ridings Figueroa, Elizabeth E Palmer, Angela T Morgan","doi":"10.1002/ajmg.a.64192","DOIUrl":null,"url":null,"abstract":"<p><p>Speech and language difficulties are a core feature of the CLCN4-related neurodevelopmental condition, but these have not been well described. Here we systematically phenotype speech and language in 13 participants (10 female, aged 1 year 10 months-41 years 10 months) with pathogenic CLCN4 variants (12 missense de novo, 1 premature stop codon maternal inheritance). Speech, language, and augmentative and alternative communication (AAC) methods were examined. Expressive and receptive language conditions were highly penetrant (12/13, 92%). Eight participants were minimally verbal but used a range of low (e.g., gesture) and high-tech (e.g., device) methods to communicate. Verbal participants had both apraxia and dysarthria, characterized by inconsistent productions, sound distortions, resonance changes, and persistent voice quality and prosodic errors. Participants were all intentional communicators, being motivated to get their message across. A discrepancy was present, however, between the ability to express basic needs versus demonstrate social skills or social exchanges. Data highlight the potential for the implementation of tailored AAC to enhance functional social participation and extend language abilities. Communication difficulties are pervasive in CLCN4-related neurodevelopmental condition. Data emphasize the importance of individualized and timely speech therapy, and particularly the introduction of AAC to optimize language growth.</p>","PeriodicalId":7507,"journal":{"name":"American Journal of Medical Genetics Part A","volume":" ","pages":"e64192"},"PeriodicalIF":1.7000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medical Genetics Part A","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/ajmg.a.64192","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Speech and language difficulties are a core feature of the CLCN4-related neurodevelopmental condition, but these have not been well described. Here we systematically phenotype speech and language in 13 participants (10 female, aged 1 year 10 months-41 years 10 months) with pathogenic CLCN4 variants (12 missense de novo, 1 premature stop codon maternal inheritance). Speech, language, and augmentative and alternative communication (AAC) methods were examined. Expressive and receptive language conditions were highly penetrant (12/13, 92%). Eight participants were minimally verbal but used a range of low (e.g., gesture) and high-tech (e.g., device) methods to communicate. Verbal participants had both apraxia and dysarthria, characterized by inconsistent productions, sound distortions, resonance changes, and persistent voice quality and prosodic errors. Participants were all intentional communicators, being motivated to get their message across. A discrepancy was present, however, between the ability to express basic needs versus demonstrate social skills or social exchanges. Data highlight the potential for the implementation of tailored AAC to enhance functional social participation and extend language abilities. Communication difficulties are pervasive in CLCN4-related neurodevelopmental condition. Data emphasize the importance of individualized and timely speech therapy, and particularly the introduction of AAC to optimize language growth.
期刊介绍:
The American Journal of Medical Genetics - Part A (AJMG) gives you continuous coverage of all biological and medical aspects of genetic disorders and birth defects, as well as in-depth documentation of phenotype analysis within the current context of genotype/phenotype correlations. In addition to Part A , AJMG also publishes two other parts:
Part B: Neuropsychiatric Genetics , covering experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders.
Part C: Seminars in Medical Genetics , guest-edited collections of thematic reviews of topical interest to the readership of AJMG .